We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03443024
Brief Title: A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

First Submitted : February 16, 2018
First Submitted that Met QC Criteria : February 16, 2018
First Posted : February 22, 2018

Results First Submitted : April 9, 2021
Results First Submitted that Met QC Criteria : April 9, 2021
Results First Posted : May 4, 2021

Certification/Extension First Submitted : March 27, 2020
Certification/Extension First Submitted that Met QC Criteria : March 27, 2020
Certification/Extension First Posted : April 3, 2020

Last Update Submitted that Met QC Criteria : April 9, 2021
Last Update Posted : May 4, 2021